Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments to CMS about Proposed Changes to the PFS for CY 2021
-
Joint Comments to CMS Concerning MolDx Program, Medicare Coverage, and Impact on MoPath Gapfill Determinations
-
ACMG Letter to Palmetto GBA Requesting Reconsideration of Cytogenetic Microarray Coverage